Form 4 for MRNA Moderna
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-30 · accession 0001127602-25-016205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-02 | 2025-05-30 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 26.4K | +0.9% | — |
| D | 2025-06-02 | 2025-05-30 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $26.93 | -113 | 26.3K | -0.4% | -$3,043 |
| D | 2025-06-02 | 2025-05-30 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -233 | 698 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | M | A | 233 | — | 26,413 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-05-30 | F | D | 113 | $26.93 | 26,300 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-05-30 | M | D | 233 | $0.00 | 698 | D | — · — to — | 233 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |